Lupin Ltd. (LUPN.BO) Purchases Instem Preclinical Software for Novel Drug Discovery & Development Program  
5/1/2012 10:46:30 AM

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Lupin Limited (Lupin) has purchased the Provantis® preclinical software solution. Provantis will be deployed at the Lupin Research Park, the company’s state-of-the art global R&D hub in Pune, India, housing over 1,000 scientists.